| Literature DB >> 1346411 |
R Goldsmith1, P O Yarbough, G R Reyes, K E Fry, K A Gabor, M Kamel, S Zakaria, S Amer, Y Gaffar.
Abstract
Hepatitis E virus (HEV) is thought to be a cause of enterically transmitted non-A, non-B (ET-NANB) hepatitis. Waterborne epidemics have been recorded in many developing countries, mainly affecting young-to-middle-aged adults; sporadic infection and overt illness in children are rare. However, a convenient and sensitive diagnostic test for HEV infection is not yet available. We now report the use of a solid-phase enzyme-linked immunoassay (ELISA) that detects IgM and IgG antibody to HEV. In a prospective study of endemic acute hepatitis during 1986 in rural Benha, Egypt, 15 (42%) of 36 children with NANB hepatitis (from whom convalescent-phase sera were available every 3 months to 9 or 12 months) were positive for anti-HEV-IgG by ELISA. Of 20 sera from healthy Benha children (controls), 5 (25%) were also positive for anti-HEV-IgG. When evaluated for anti-HEV-IgM, 6 of the 15 IgG-positive children, but none of the controls, were IgM positive and were thus regarded as having confirmed acute HEV infections. These 6 cases together with 2 presumptive cases (IgM negative, IgG seroconversion from positive to negative) presented sporadically over 9 months. This ELISA is a convenient method for the diagnosis of HEV infection; we have shown that the disease is present in Egypt, that it can occur endemically as sporadic cases, and that children do have overt infection.Entities:
Keywords: Africa; Age Factors; Antibodies--analysis; Arab Countries; Biology; Child; Demographic Factors; Developing Countries; Diseases; Egypt; Examinations And Diagnoses; Hematologic Tests; Hepatitis; Immunity; Immunologic Factors; Laboratory Examinations And Diagnoses; Laboratory Procedures; Mediterranean Countries; Northern Africa; Physiology; Population; Population Characteristics; Prospective Studies; Research Methodology; Studies; Viral Diseases; Youth
Mesh:
Substances:
Year: 1992 PMID: 1346411 DOI: 10.1016/0140-6736(92)91647-q
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321